Ana Dopazo

Ana Dopazo

Auto-generated profile, based on publicly available information

Ana Dopazo

Genomics Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in Nature
Verified
Journal Article
Open access
PDF file
VMVictoria Moiseeva
Victoria Moiseeva
ACAndrés Cisneros
Andrés Cisneros
VSValentina Sica
Valentina Sica
ODOleg Deryagin
Oleg Deryagin
YLYiwei Lai
Yiwei Lai
PMPura Muñoz-Cánoves
Pura Muñoz-Cánoves
Tissue regeneration requires coordination between resident stem cells and local niche cells1,2. Here we identify that senescent cells are integral components of the skeletal muscle regenerative niche that repress regeneration at all stages of life. The technical limitation of senescent-cell scarcity3was overcome by combining single-cell transcriptomics and a senescent-cell enrichment sorting protocol. We identified and isolated different senescent cell types from damaged muscles of young and old mice. Deeper transcriptome, chromatin and pathway analyses revealed conservation of cell identity traits as well as two universal senescence hallmarks (inflammation and fibrosis) across cell type, regeneration time and ageing. Senescent cells create an aged-like inflamed niche that mirrors inflammation associated with ageing (inflammageing4) and arrests stem cell proliferation and regeneration. Reducing the burden of senescent cells, or reducing their inflammatory secretome through CD36 neutralization, accelerates regeneration in young and old mice. By contrast, transplantation of senescent cells delays regeneration. Our results provide a technique for isolating in vivo senescent cells, define a senescence blueprint for muscle, and uncover unproductive functional interactions between senescent cells and stem cells in regenerative niches that can be overcome. As senescent cells also accumulate in human muscles, our findings open potential paths for improving muscle repair throughout life.

17 December 2010 in Cell Death & Differentiation
Verified
Journal Article
Closed access
MTM Tomé
M Tomé
PLP López-Romero
P López-Romero
CAC Albo
C Albo
JSJ C Sepúlveda
J C Sepúlveda
BFBenjamin Fernandez-Gutierrez
Benjamin Fernandez-Gutierrez
MGM A González
M A González

2 December 2011 in Cell Death & Differentiation
Verified
Journal Article
Closed access
JEJ C Estrada
J C Estrada
CAC Albo
C Albo
ABA Benguría
A Benguría
ADA Dopazo
A Dopazo
PLP López-Romero
P López-Romero
ESE Samper
E Samper

6 August 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KGK M Gautvik
K M Gautvik
LLL de Lecea
L de Lecea
VGV T Gautvik
V T Gautvik
PDP E Danielson
P E Danielson
PTP Tranque
P Tranque
JSJ G Sutcliffe
J G Sutcliffe
We applied the directional tag PCR subtractive hybridization method to construct a rat hypothalamic cDNA library from which cerebellar and hippocampal sequences had been depleted, enriching 20-30-fold for sequences expressed selectively in the hypothalamus. We studied a sample of 94 clones selected for enrichment in the subtracted library. These clones corresponded to 43 distinct mRNA species, about half of which were novel. Thirty-eight of these 43 mRNAs (corresponding to 85 of the clones in the sample) exhibited enrichment in the hypothalamus; 23 were highly enriched. In situ hybridization studies revealed that one novel species was restricted to cells in a small bilaterally symmetric area of the paraventricular hypothalamus. Other novel mRNAs showed substantial enrichment in basal diencephalic structures, particularly the hypothalamus, without restriction to single hypothalamic nuclei. The data suggest that the hypothalamus utilizes at least two distinct strategies for employing its selectively expressed proteins. Secretory neuropeptides utilized for intercellular communication are produced by functionally discrete nuclei, while several other proteins are shared by structures that are unrelated in their physiological roles but may share biochemical systems.

27 June 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JEJ C Estrada
J C Estrada
YTY Torres
Y Torres
ABA Benguría
A Benguría
ADA Dopazo
A Dopazo
Enrique  RocheEnrique  Roche
Enrique  Roche
ABA Bernad
A Bernad
In most clinical trials, human mesenchymal stem cells (hMSCs) are expanded in vitro before implantation. The genetic stability of human stem cells is critical for their clinical use. However, the relationship between stem-cell expansion and genetic stability is poorly understood. Here, we demonstrate that within the normal expansion period, hMSC cultures show a high percentage of aneuploid cells that progressively increases until senescence. Despite this accumulation, we show that in a heterogeneous culture the senescence-prone hMSC subpopulation has a lower proliferation potential and a higher incidence of aneuploidy than the non-senescent subpopulation. We further show that senescence is linked to a novel transcriptional signature that includes a set of genes implicated in ploidy control. Overexpression of the telomerase catalytic subunit (human telomerase reverse transcriptase, hTERT) inhibited senescence, markedly reducing the levels of aneuploidy and preventing the dysregulation of ploidy-controlling genes. hMSC-replicative senescence was accompanied by an increase in oxygen consumption rate (OCR) and oxidative stress, but in long-term cultures that overexpress hTERT, these parameters were maintained at basal levels, comparable to unmodified hMSCs at initial passages. We therefore propose that hTERT contributes to genetic stability through its classical telomere maintenance function and also by reducing the levels of oxidative stress, possibly, by controlling mitochondrial physiology. Finally, we propose that aneuploidy is a relevant factor in the induction of senescence and should be assessed in hMSCs before their clinical use.

20 June 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
FSFatima Sanchez-Cabo
Fatima Sanchez-Cabo
VFValentín Fuster
Valentín Fuster
JSJuan Carlos Silla-Castro
Juan Carlos Silla-Castro
GGGema González
Gema González
ELErika Lorenzo-Vivas
Erika Lorenzo-Vivas
ELEnrique Lara-Pezzi
Enrique Lara-Pezzi
Epigenetic age is emerging as a personalized and accurate predictor of biological age. The aim of this article is to assess the association of subclinical atherosclerosis with accelerated epigenetic age and to investigate the underlying mechanisms mediating this association. Whole blood methylomics, transcriptomics, and plasma proteomics were obtained for 391 participants of the Progression of Early Subclinical Atherosclerosis study. Epigenetic age was calculated from methylomics data for each participant. Its divergence from chronological age is termed epigenetic age acceleration. Subclinical atherosclerosis burden was estimated by multi-territory 2D/3D vascular ultrasound and by coronary artery calcification. In healthy individuals, the presence, extension, and progression of subclinical atherosclerosis were associated with a significant acceleration of the Grim epigenetic age, a predictor of health and lifespan, regardless of traditional cardiovascular risk factors. Individuals with an accelerated Grim epigenetic age were characterized by an increased systemic inflammation and associated with a score of low-grade, chronic inflammation. Mediation analysis using transcriptomics and proteomics data revealed key pro-inflammatory pathways (IL6, Inflammasome, and IL10) and genes (IL1B, OSM, TLR5, and CD14) mediating the association between subclinical atherosclerosis and epigenetic age acceleration. The presence, extension, and progression of subclinical atherosclerosis in middle-aged asymptomatic individuals are associated with an acceleration in the Grim epigenetic age. Mediation analysis using transcriptomics and proteomics data suggests a key role of systemic inflammation in this association, reinforcing the relevance of interventions on inflammation to prevent cardiovascular disease. The accelerated epigenetic age of individuals with subclinical atherosclerosis is mediated by a low-grade, chronic, systemic inflammation driven by key inflammatory cytokines and pathways.